PETAH TIKVA, Israel & BOCA RATON, Fla., December 30, 2025--(BUSINESS WIRE)--Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system ...

The company will use the money to try to establish its cuffless device as a go-to option for 24-hour blood pressure ...

Show the patient how to place the device on the bed or beneath a pillow during sleep Show the patient how to turn off the device in case of malfunction Provide instructions for filling out a diary ...

Biobeat Secures $50 Million Series B Financing to Advance Commercialization of its Patch-worn, Cuff-less 24-hour Ambulatory Blood Pressure Monitor Biobeat Technologies, Ltd., developer of the first ...

Cuff-based ABPM devices have historically been underutilized due to their frequent and disruptive inflation cycles resulting in low patient compliance and logistical device and data collection issues ...

Biobeat Technologies, Ltd., developer of the first FDA-cleared, 24-hour ambulatory blood pressure monitoring (ABPM) system that is a patch-worn, cuff-less solution for diagnosis and treatment of ...